8-K
Current Report
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-23-031458
Material agreement · Agreement ended · New debt or obligation
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
From the SEC's structured data for this filing
Loading cpix-20230905.htm…